Palliative treatment of hepatocellular carcinoma. Is it justified?

被引：0

作者：

Michalowicz, B ^{[1
]}

Alsharabi, A ^{[1
]}

Pawlak, J ^{[1
]}

Krawczyk, M ^{[1
]}

Paczkowski, PM ^{[1
]}

Malkowski, P ^{[1
]}

Zieniewicz, K ^{[1
]}

Nyckowski, P ^{[1
]}

Karwowski, A ^{[1
]}

Rowinski, O ^{[1
]}

Jaworski, M ^{[1
]}

Leowska, E ^{[1
]}

机构：

[1] Univ Warsaw, Dept Gen & Liver Surg, Warsaw, Poland

来源：

8TH WORLD CONGRESS OF THE INTERNATIONAL GASTRO-SURGICAL CLUB | 1998年

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In the period 1992-1995 313 patients were treated for malignant liver tumors. The diagnosis of hepatocellular carcinoma was established in 118 cases. In 84 cases the tumor was inoperable. We present our experience with intraoperative alcoholization (19 cases) and perarterial chemoembolization (43 cases). None of these methods is effective in all cases. Etanol injection resulted in temporary reduction of the neoplasmatic mass in 73%. Repeated chemoembolization resulted in significant improvement in 20 cases, in 16 cases it's effect was doubtful and in 7 cases it was evidently uneffective. 18 patients (42%) survived more than one year, in 15 of them no progress of malignancy was noticed.

引用

页码：413 / 418

页数：6

共 50 条

[41] Hepatocellular carcinoma. Therapeutic perspectives
Mohr, L.
GASTROENTEROLOGE, 2007, 2 (01): : 34 - 39
[42] Palliative bypass surgery for periampullary carcinoma.
Geenen, RC
Dekker, CM
Gulik, TM
Obertop, H
Gouma, DJ
GASTROENTEROLOGY, 2000, 118 (04) : A1146 - A1146
[43] SURGICAL TREATMENT FOR HEPATOCELLULAR CARCINOMA PATIENTS OUT OF MILAN CRITERIA: IS TRANSPLANTATION JUSTIFIED?
Fan, Hsiu-Lung
Hsieh, Chung-Bao
Chen, Teng-Wei
LIVER TRANSPLANTATION, 2008, 14 (07) : S87 - S88
[44] PALLIATIVE TREATMENT OF HEPATOCELLULAR-CARCINOMA WITH TRANSCATHETER ARTERIAL EMBOLIZATION
SAVASTANO, S
FELTRIN, GP
NERI, D
DAPIAN, P
CHIESURACORONA, M
ROMAN, E
BATTAGLIA, G
GERUNDA, G
LISE, M
MIOTTO, D
ACTA RADIOLOGICA, 1993, 34 (01) : 26 - 29
[45] Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma
Gerhild Becker
Tarik Soezgen
Manfred Olschewski
Joerg Laubenberger
Hubert Erich Blum
Hans-Peter Allgaier
World Journal of Gastroenterology, 2005, (39) : 6104 - 6109
[46] PERCUTANEOUS TREATMENT OF HEPATOCELLULAR CARCINOMA. SYSTEMATIC REVIEW AND META-ANALYSIS
Pleguezuelo, M.
Germani, G.
Gurusamy, K.
Calvaruso, V.
Manousou, P.
Arvaniti, V.
Triantos, C.
Burroughs, A. K.
JOURNAL OF HEPATOLOGY, 2009, 50 : S297 - S297
[47] Practical screening and early treatment of hepatocellular carcinoma.: Results of a French survey
Ganne-Carrié, N
Chevret, S
Barbare, JC
Chaffaud, C
Grando, V
Vogt, AM
Beaugrand, M
Trinchet, JC
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (6-7): : 570 - 577
[48] Percutaneous intratumoral injection of holmium-166 for the treatment of hepatocellular carcinoma.
Han, KH
Lee, CK
Lee, IT
Choi, W
Lee, KS
Chon, CY
Moon, YM
Park, KB
HEPATOLOGY, 1997, 26 (04) : 462 - 462
[49] Systemic therapy for hepatocellular carcinoma: more than "palliative" treatment?
Ben Khaled, Najib
Reiter, Florian P.
Geier, Andreas
De Toni, Enrico N.
GASTROENTEROLOGIE, 2023, 18 (01): : 24 - 29
[50] Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma
Becker, Gerhild
Soezgen, Tarik
Olschewski, Manfred
Laubenberger, Joerg
Blum, Hubert Erich
Allgaier, Hans-Peter
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (39) : 6104 - 6109

← 1 2 3 4 5 →